gamma-Glutamyltransferase in the newborn

Area of Science:

• Neonatal Medicine
• Clinical Chemistry
• Pediatric Gastroenterology

Background:

• Gamma-glutamyltransferase (GGT) is an enzyme relevant to liver function.
• Understanding GGT levels in newborns is crucial for monitoring infant health.
• Established reference ranges for neonatal GGT are important for clinical interpretation.

Purpose of the Study:

• To investigate serial changes in gamma-glutamyltransferase (GGT) activity in newborn infants.
• To determine the relationship between GGT levels and factors like gestational age, phenobarbitone treatment, and feeding methods.
• To evaluate the utility of GGT as a biomarker for total parenteral nutrition (TPN)-induced liver injury.

Main Methods:

• Serial measurement of serum gamma-glutamyltransferase (GGT) activity in a cohort of newborn infants.
• Analysis of GGT levels in relation to gestational age, phenobarbitone administration, and initiation of oral feeding following parenteral nutrition.
• Correlation of GGT levels with the presence or absence of liver damage associated with TPN.

Main Results:

• The median GGT activity in newborns was 94 units/l, with the 95th centile at 243 units/l.
• GGT activity was not significantly correlated with gestational age.
• Significant increases in GGT were observed following phenobarbitone treatment and the introduction of oral feeding after parenteral nutrition.

Conclusions:

• Gamma-glutamyltransferase levels in newborns are influenced by specific treatments and feeding transitions.
• GGT is not a reliable indicator of liver damage in infants receiving total parenteral nutrition (TPN).
• Further research may be needed to identify sensitive biomarkers for TPN-related liver complications in neonates.